Form 4: Century Therapeutics' Chief Operations Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Adrienne Farid, Chief Operations Officer of Century Therapeutics, sold 1,033 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On November 4, 2024, Adrienne Farid, the Chief Operations Officer of Century Therapeutics, sold 1,033 shares of the company's common stock.
- The sale was executed at a price of $1.227 per share.
- This transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
- Following the transaction, Farid directly owns 135,130 shares of Century Therapeutics.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock sales for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Key Dates
| Date | Description |
|---|---|
| 11/04/2024 | Date of stock sale transaction. |
| 11/05/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.